In a recent episode of "The Rank" on Fool Live, three of our contributors -- Matt Frankel, Jason Hall, and Danny Vena -- shared their highest conviction stocks for 2022. In this clip, recorded on Jan.
MercadoLibre (NASDAQ: MELI), the largest e-commerce company in Latin America, nearly tripled its market capitalization in 2020 as its growth accelerated throughout the pandemic. Does that pullback represent a good buying opportunity for investors who missed out on MercadoLibre's multibagger gains over the past two decades? The bears believe that challenging year-over-year comparisons, rising expenses, aggressive competitors, and macroeconomic headwinds will limit MercadoLibre's gains this year.
Growth stocks, particularly those that thrived at the peak of the coronavirus pandemic, largely fell out of style in 2021. With that in mind, let's look at two growth stocks that appear well-positioned to deliver above-average returns for many years to come: DexCom (NASDAQ: DXCM) and MercadoLibre (NASDAQ: MELI). DexCom is a medical device company that focuses on helping diabetes patients achieve better health outcomes.